Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL NANOPARTICLES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL NANOPARTICLES MARKET SIZE
2.3 VENDOR POSITIONING GRID
2.4 MARKETS COVERED
2.5 GEOGRAPHIC SCOPE
2.6 YEARS CONSIDERED FOR THE STUDY
2.7 RESEARCH METHODOLOGY
2.8 TECHNOLOGY LIFE LINE CURVE
2.9 MULTIVARIATE MODELLING
2.1 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.11 DBMR MARKET POSITION GRID
2.12 MARKET APPLICATION COVERAGE GRID
2.13 DBMR MARKET CHALLENGE MATRIX
2.14 IMPORT AND EXPORT DATA
2.15 SECONDARY SOURCES
2.16 GLOBAL NANOPARTICLES MARKET: RESEARCH SNAPSHOT
2.17 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PRODUCTION CONSUMPTION ANALYSIS
5.2 IMPORT EXPORT SCENARIO
5.3 RAW MATERIAL PRODUCTION COVERAGE
5.4 TECHNOLOGICAL ADVANCEMENT BY MANUFACTURERS
5.5 LIST OF KEY BUYERS, BY REGION
5.5.1 NORTH AMERICA
5.5.2 EUROPE
5.5.3 ASIA PACIFIC
5.5.4 SOUTH AMERICA
5.5.5 MIDDLE EAST & AFRICA
5.6 PORTER’S FIVE FORCES
5.7 VENDOR SELECTION CRITERIA
5.8 PESTEL ANALYSIS
5.9 REGULATION COVERAGE
5.9.1 PRODUCT CODES
5.9.2 CERTIFIED STANDARDS
5.9.3 SAFETY STANDARDS
5.9.3.1. MATERIAL HANDLING & STORAGE
5.9.3.2. TRANSPORT & PRECAUTIONS
6 SUPPLY CHAIN ANALYSIS
6.1 OVERVIEW
6.2 LOGISTIC COST SCENARIO
6.3 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS
7 CLIMATE CHANGE SCENARIO
7.1 ENVIRONMENTAL CONCERNS
7.2 INDUSTRY RESPONSE
7.3 GOVERNMENT’S ROLE
7.4 ANALYST RECOMMENDATIONS
8 GLOBAL NANOPARTICLES MARKET, BY PRODUCT, 2020-2029, (KILO TONS) (USD MILLION)
8.1 OVERVIEW
8.2 LIPOSOMES
8.3 POLYMER-CONJUGATED DRUGS
8.4 POLYMERIC NANOPARTICLES
8.4.1 BY FORM
8.4.1.1. NANOSPHERES
8.4.1.2. NANOCAPSULES
8.4.2 BY CATEGORY
8.4.2.1. DAB
8.4.2.2. PAMAM
8.4.3 BY POLYMER
8.4.3.1. SYNTHETIC POLYMERS
8.4.3.1.1. PLA
8.4.3.1.2. PLGA
8.4.3.1.3. PCL
8.4.3.1.4. PICBA
8.4.3.1.5. PIHCA
8.4.3.1.6. OTHERS
8.4.3.2. NATURAL POLYMERS
8.4.3.2.1. CHITOSAN
8.4.3.2.2. ALGINATE
8.4.3.2.3. GELATIN
8.4.3.2.4. ALBUMIN
8.4.3.3. COPOLYMERS
8.4.3.3.1. PLA-PEG
8.4.3.3.2. PLGA-PEG
8.4.3.3.3. PCL-PEG
8.4.3.3.4. POLY (HDCA-PEGCA)
8.4.3.4. COLLOID STABILISERS
8.4.3.4.1. DEXTRAN
8.4.3.4.2. PLURONIC
8.4.3.4.3. POLY VINYL ALCOHOL
8.4.3.4.4. OTHERS
8.5 DENDRIMERS
8.6 INORGANIC NANOPARTICLES
8.6.1 BY SEGMENT
8.6.1.1. GOLD NANOPARTICLES
8.6.1.2. IRON OXIDE MAGNETIC NANOPARTICLE
8.6.1.3. OTHERS
8.7 OTHERS
9 GLOBAL NANOPARTICLES MARKET, BY APPLICATION, 2020-2029, (KILO TONS) (USD MILLION)
9.1 OVERVIEW
9.2 HEALTHCARE
9.2.1 BY SEGMENT
9.2.1.1. BIOTECHNOLOGY
9.2.1.2. DRUG DEVELOPMENT
9.2.1.3. DRUG DELIVERY
9.2.2 BY PRODUCT
9.2.2.1. LIPOSOMES
9.2.2.2. POLYMER-CONJUGATED DRUGS
9.2.2.3. POLYMERIC NANOPARTICLES
9.2.2.4. DENDRIMERS
9.2.2.5. INORGANIC NANOPARTICLES
9.2.2.6. OTHERS
9.3 PHARMACEUTICALS
9.3.1 BY PRODUCT
9.3.1.1. LIPOSOMES
9.3.1.2. POLYMER-CONJUGATED DRUGS
9.3.1.3. POLYMERIC NANOPARTICLES
9.3.1.4. DENDRIMERS
9.3.1.5. INORGANIC NANOPARTICLES
9.3.1.6. OTHERS
9.4 ELECTRONICS
9.4.1 BY PRODUCT
9.4.1.1. LIPOSOMES
9.4.1.2. POLYMER-CONJUGATED DRUGS
9.4.1.3. POLYMERIC NANOPARTICLES
9.4.1.4. DENDRIMERS
9.4.1.5. INORGANIC NANOPARTICLES
9.4.1.6. OTHERS
9.5 AUTOMOTIVE
9.5.1 BY PRODUCT
9.5.1.1. LIPOSOMES
9.5.1.2. POLYMER-CONJUGATED DRUGS
9.5.1.3. POLYMERIC NANOPARTICLES
9.5.1.4. DENDRIMERS
9.5.1.5. INORGANIC NANOPARTICLES
9.5.1.6. OTHERS
9.6 BUILDING & CONSTRUCTION
9.6.1 BY PRODUCT
9.6.1.1. LIPOSOMES
9.6.1.2. POLYMER-CONJUGATED DRUGS
9.6.1.3. POLYMERIC NANOPARTICLES
9.6.1.4. DENDRIMERS
9.6.1.5. INORGANIC NANOPARTICLES
9.6.1.6. OTHERS
9.7 PACKAGING
9.7.1 BY PRODUCT
9.7.1.1. LIPOSOMES
9.7.1.2. POLYMER-CONJUGATED DRUGS
9.7.1.3. POLYMERIC NANOPARTICLES
9.7.1.4. DENDRIMERS
9.7.1.5. INORGANIC NANOPARTICLES
9.7.1.6. OTHERS
9.8 AEROSPACE & DEFENCE
9.8.1 BY PRODUCT
9.8.1.1. LIPOSOMES
9.8.1.2. POLYMER-CONJUGATED DRUGS
9.8.1.3. POLYMERIC NANOPARTICLES
9.8.1.4. DENDRIMERS
9.8.1.5. INORGANIC NANOPARTICLES
9.8.1.6. OTHERS
9.9 OTHERS
9.9.1 BY PRODUCT
9.9.1.1. LIPOSOMES
9.9.1.2. POLYMER-CONJUGATED DRUGS
9.9.1.3. POLYMERIC NANOPARTICLES
9.9.1.4. DENDRIMERS
9.9.1.5. INORGANIC NANOPARTICLES
9.9.1.6. OTHERS
10 GLOBAL NANOPARTICLES MARKET, BY GEOGRAPHY, (USD MILLION)
10.1 GLOBAL NANOPARTICLES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
10.2 NORTH AMERICA
10.2.1 U.S.
10.2.2 CANADA
10.2.3 MEXICO
10.3 EUROPE
10.3.1 GERMANY
10.3.2 U.K.
10.3.3 ITALY
10.3.4 FRANCE
10.3.5 SPAIN
10.3.6 RUSSIA
10.3.7 SWITZERLAND
10.3.8 TURKEY
10.3.9 BELGIUM
10.3.10 NETHERLANDS
10.3.11 LUXEMBURG
10.3.12 REST OF EUROPE
10.4 ASIA-PACIFIC
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 SOUTH KOREA
10.4.4 INDIA
10.4.5 SINGAPORE
10.4.6 THAILAND
10.4.7 INDONESIA
10.4.8 MALAYSIA
10.4.9 PHILIPPINES
10.4.10 AUSTRALIA & NEW ZEALAND
10.4.11 REST OF ASIA-PACIFIC
10.5 SOUTH AMERICA
10.5.1 BRAZIL
10.5.2 ARGENTINA
10.5.3 REST OF SOUTH AMERICA
10.6 MIDDLE EAST AND AFRICA
10.6.1 SOUTH AFRICA
10.6.2 EGYPT
10.6.3 SAUDI ARABIA
10.6.4 UNITED ARAB EMIRATES
10.6.5 ISRAEL
10.6.6 REST OF MIDDLE EAST AND AFRICA
11 GLOBAL NANOPARTICLES MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: GLOBAL
11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
11.3 COMPANY SHARE ANALYSIS: EUROPE
11.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
11.5 MERGERS AND ACQUISITIONS
11.6 NEW PRODUCT DEVELOPMENT AND APPROVALS
11.7 EXPANSIONS
11.8 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
12 SWOT AND DATA BRIDGE MARKET RESEARCH ANALYSIS
13 GLOBAL NANOPARTICLES MARKET - COMPANY PROFILES
13.1 NOVARTIS INTERNATIONAL AG
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 PRODUCT PORTFOLIO
13.1.4 RECENT UPDATES
13.2 GILEAD SCIENCES, INC.
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 PRODUCT PORTFOLIO
13.2.4 RECENT UPDATES
13.3 ABRAXIS BIOSCIENCES, INC.
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 PRODUCT PORTFOLIO
13.3.4 RECENT UPDATES
13.4 SIGMA-TAU PHARMACEUTICALS, INC.
13.4.1 COMPANY SNAPSHOT
13.4.2 REVENUE ANALYSIS
13.4.3 PRODUCT PORTFOLIO
13.4.4 RECENT UPDATES
13.5 AMGEN, INC.
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 PRODUCT PORTFOLIO
13.5.4 RECENT UPDATES
13.6 NANO INTERFACE TECHNOLOGY, INC.
13.6.1 COMPANY SNAPSHOT
13.6.2 REVENUE ANALYSIS
13.6.3 PRODUCT PORTFOLIO
13.6.4 RECENT UPDATES
13.7 ARKEMA
13.7.1 COMPANY SNAPSHOT
13.7.2 REVENUE ANALYSIS
13.7.3 PRODUCT PORTFOLIO
13.7.4 RECENT UPDATES
13.8 NANOPHASE TECHNOLOGIES CORPORATION
13.8.1 COMPANY SNAPSHOT
13.8.2 REVENUE ANALYSIS
13.8.3 PRODUCT PORTFOLIO
13.8.4 RECENT UPDATES
13.9 CABOT CORPORATION
13.9.1 COMPANY SNAPSHOT
13.9.2 REVENUE ANALYSIS
13.9.3 PRODUCT PORTFOLIO
13.9.4 RECENT UPDATESA
13.1 ZYVEX INSTRUMENTS
13.10.1 COMPANY SNAPSHOT
13.10.2 REVENUE ANALYSIS
13.10.3 PRODUCT PORTFOLIO
13.10.4 RECENT UPDATES
13.11 NANOSHEL LLC
13.11.1 COMPANY SNAPSHOT
13.11.2 REVENUE ANALYSIS
13.11.3 PRODUCT PORTFOLIO
13.11.4 RECENT UPDATES
13.12 APHIOS CORPORATION
13.12.1 COMPANY SNAPSHOT
13.12.2 REVENUE ANALYSIS
13.12.3 PRODUCT PORTFOLIO
13.12.4 RECENT UPDATES
13.13 CD BIOPARTICLES
13.13.1 COMPANY SNAPSHOT
13.13.2 REVENUE ANALYSIS
13.13.3 PRODUCT PORTFOLIO
13.13.4 RECENT UPDATES
13.14 PHOSPHOREX, INC.
13.14.1 COMPANY SNAPSHOT
13.14.2 REVENUE ANALYSIS
13.14.3 PRODUCT PORTFOLIO
13.14.4 RECENT UPDATES
13.15 MERCK KGAA
13.15.1 COMPANY SNAPSHOT
13.15.2 REVENUE ANALYSIS
13.15.3 PRODUCT PORTFOLIO
13.15.4 RECENT UPDATES
13.16 DSM
13.16.1 COMPANY SNAPSHOT
13.16.2 REVENUE ANALYSIS
13.16.3 PRODUCT PORTFOLIO
13.16.4 RECENT UPDATES
13.17 STATNANO
13.17.1 COMPANY SNAPSHOT
13.17.2 REVENUE ANALYSIS
13.17.3 PRODUCT PORTFOLIO
13.17.4 RECENT UPDATES
13.18 PRECISION NANOSYSTEMS
13.18.1 COMPANY SNAPSHOT
13.18.2 REVENUE ANALYSIS
13.18.3 PRODUCT PORTFOLIO
13.18.4 RECENT UPDATES
13.19 NANOCOMPOSIX
13.19.1 COMPANY SNAPSHOT
13.19.2 REVENUE ANALYSIS
13.19.3 PRODUCT PORTFOLIO
13.19.4 RECENT UPDATES
13.2 ARDENA HOLDING NV
13.20.1 COMPANY SNAPSHOT
13.20.2 REVENUE ANALYSIS
13.20.3 PRODUCT PORTFOLIO
13.20.4 RECENT UPDATES
13.21 ALFA AESAR
13.21.1 COMPANY SNAPSHOT
13.21.2 REVENUE ANALYSIS
13.21.3 PRODUCT PORTFOLIO
13.21.4 RECENT UPDATES
13.22 GRAY
13.22.1 COMPANY SNAPSHOT
13.22.2 REVENUE ANALYSIS
13.22.3 PRODUCT PORTFOLIO
13.22.4 RECENT UPDATES
13.23 SRL
13.23.1 COMPANY SNAPSHOT
13.23.2 REVENUE ANALYSIS
13.23.3 PRODUCT PORTFOLIO
13.23.4 RECENT UPDATES
13.24 NANORH
13.24.1 COMPANY SNAPSHOT
13.24.2 REVENUE ANALYSIS
13.24.3 PRODUCT PORTFOLIO
13.24.4 RECENT UPDATES
13.25 ELEMENTIS SPECIALTIES
13.25.1 COMPANY SNAPSHOT
13.25.2 REVENUE ANALYSIS
13.25.3 PRODUCT PORTFOLIO
13.25.4 RECENT UPDATES
*NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
14 RELATED REPORTS
15 QUESTIONNAIRE
16 CONCLUSION
17 ABOUT DATA BRIDGE MARKET RESEARCH
